Literature DB >> 21940840

Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.

Julia J Scialla1, Mary B Leonard, Raymond R Townsend, Lawrence Appel, Myles Wolf, Matt J Budoff, Jing Chen, Eva Lustigova, Crystal A Gadegbeku, Melanie Glenn, Asaf Hanish, Dominic Raj, Sylvia E Rosas, Stephen L Seliger, Matthew R Weir, Rulan S Parekh.   

Abstract

BACKGROUND AND OBJECTIVES: Osteoprotegerin (OPG), a cytokine that regulates bone resorption, has been implicated in the process of vascular calcification and stiffness. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Serum OPG was measured in 351 participants with chronic kidney disease (CKD) from one site of the Chronic Renal Insufficiency Cohort Study. Cortical bone mineral content (BMC) was measured by quantitative computed tomography in the tibia. Multivariable linear regression was used to test the association between serum OPG and traditional cardiovascular risk factors, measures of abnormal bone and mineral metabolism, and pulse wave velocity.
RESULTS: Higher serum OPG levels were associated with older age, female gender, greater systolic BP, lower estimated GFR, and lower serum albumin. OPG was not associated with measures of abnormal bone or mineral metabolism including serum phosphorus, albumin-corrected serum calcium, intact parathyroid hormone, bone-specific alkaline phosphatase, or cortical BMC. Among 226 participants with concurrent aortic pulse wave velocity measurements, increasing tertiles of serum OPG were associated with higher aortic pulse wave velocity after adjustment for demographics, traditional vascular risk factors, and nontraditional risk factors such as estimated GFR, albuminuria, serum phosphate, corrected serum calcium, presence of secondary hyperparathyroidism, serum albumin, and C-reactive protein or after additional adjustment for cortical BMC in a subset (n = 161).
CONCLUSIONS: These data support a strong relationship between serum OPG and arterial stiffness independent of many potential confounders including traditional cardiovascular risk factors, abnormal bone and mineral metabolism, and inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940840      PMCID: PMC3206002          DOI: 10.2215/CJN.03910411

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

Review 1.  Vascular calcification in chronic kidney disease.

Authors:  William G Goodman; Gerard London; Kerstin Amann; Geoffrey A Block; Cecilia Giachelli; Keith A Hruska; Markus Ketteler; Adeera Levin; Ziad Massy; David A McCarron; Paolo Raggi; Catherine Mary Shanahan; Noriaki Yorioka
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

2.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

3.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Authors:  N Bucay; I Sarosi; C R Dunstan; S Morony; J Tarpley; C Capparelli; S Scully; H L Tan; W Xu; D L Lacey; W J Boyle; W S Simonet
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 4.  Vascular calcification in chronic kidney disease.

Authors:  Shuichi Jono; Atsushi Shioi; Yuji Ikari; Yoshiki Nishizawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Cortical pQCT measures are associated with fractures in dialysis patients.

Authors:  Sophie A Jamal; Jeremy Gilbert; Christopher Gordon; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

Review 6.  Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.

Authors:  Patricia Collin-Osdoby
Journal:  Circ Res       Date:  2004-11-26       Impact factor: 17.367

7.  Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.

Authors:  Bruno Pannier; Alain P Guérin; Sylvain J Marchais; Michel E Safar; Gérard M London
Journal:  Hypertension       Date:  2005-03-07       Impact factor: 10.190

8.  Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.

Authors:  Stefan Kiechl; Georg Schett; Gregor Wenning; Kurt Redlich; Martin Oberhollenzer; Agnes Mayr; Peter Santer; Josef Smolen; Werner Poewe; Johann Willeit
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

9.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

10.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

View more
  18 in total

1.  Biomarkers of vascular calcification and mortality in patients with ESRD.

Authors:  Julia J Scialla; W H Linda Kao; Ciprian Crainiceanu; Stephen M Sozio; Pooja C Oberai; Tariq Shafi; Josef Coresh; Neil R Powe; Laura C Plantinga; Bernard G Jaar; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 2.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

Review 3.  Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review.

Authors:  Julio A Chirinos; Patrick Segers; Timothy Hughes; Raymond Townsend
Journal:  J Am Coll Cardiol       Date:  2019-09-03       Impact factor: 24.094

4.  Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.

Authors:  Anne-Sophie Bargnoux; Fernando Vetromile; Nils Kuster; Julie Barberet; Anne-Marie Dupuy; Jean Ribstein; Georges Mourad; Jean-Paul Cristol; Pierre Fesler
Journal:  J Nephrol       Date:  2015-04-29       Impact factor: 3.902

5.  Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease.

Authors:  Michalis Spartalis; Aikaterini Papagianni
Journal:  World J Nephrol       Date:  2016-01-06

Review 6.  Arterial stiffness and chronic kidney disease: lessons from the Chronic Renal Insufficiency Cohort study.

Authors:  Raymond R Townsend
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

Review 7.  Arterial Stiffness in CKD: A Review.

Authors:  Raymond R Townsend
Journal:  Am J Kidney Dis       Date:  2018-06-19       Impact factor: 8.860

Review 8.  Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings.

Authors:  Matthew Denker; Suzanne Boyle; Amanda H Anderson; Lawrence J Appel; Jing Chen; Jeffrey C Fink; John Flack; Alan S Go; Edward Horwitz; Chi-Yuan Hsu; John W Kusek; James P Lash; Sankar Navaneethan; Akinlolu O Ojo; Mahboob Rahman; Susan P Steigerwalt; Raymond R Townsend; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-11       Impact factor: 8.237

9.  Association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Authors:  Yan Chen; Leila R Zelnick; Ke Wang; Ronit Katz; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Alan S Go; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; L Hamm; Jing Chen; Tariq Shafi; Bryan R Kestenbaum
Journal:  Nephrol Dial Transplant       Date:  2020-11-17       Impact factor: 5.992

10.  Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients.

Authors:  Ji-Hung Wang; Chung-Jen Lee; Mei-Ling Chen; Chiu-Fen Yang; Yu-Chih Chen; Bang-Gee Hsu
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.